An update on the pathology and clinical management of gouty arthritis

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Gouty arthritis is an inflammatory condition associated with debilitating clinical symptoms, functional impairments, and a substantial impact on quality of life. This condition is initially triggered by the deposition of monosodium urate crystals into the joint space. This causes an inflammatory cascade resulting in the secretion of several proinflammatory cytokines and neutrophil recruitment into the joint. While generally effective, currently available agents are associated with a number of adverse events and contraindications that complicate their use. Based on our increased understanding of the inflammatory pathogenesis of gouty arthritis, several new agents are under development that may provide increased efficacy and reduced toxicity.

Original languageEnglish (US)
Pages (from-to)13-21
Number of pages9
JournalClinical Rheumatology
Volume31
Issue number1
DOIs
StatePublished - Jan 2012

Fingerprint

Gouty Arthritis
Clinical Pathology
Joints
Neutrophil Infiltration
Uric Acid
Quality of Life
Cytokines

Keywords

  • Chronic diseases
  • Gouty arthritis
  • Inflammation
  • Pathophysiology

ASJC Scopus subject areas

  • Rheumatology

Cite this

An update on the pathology and clinical management of gouty arthritis. / Gonzalez, Emilio.

In: Clinical Rheumatology, Vol. 31, No. 1, 01.2012, p. 13-21.

Research output: Contribution to journalArticle

@article{5732f5ce18cb4af887ede64c17525d41,
title = "An update on the pathology and clinical management of gouty arthritis",
abstract = "Gouty arthritis is an inflammatory condition associated with debilitating clinical symptoms, functional impairments, and a substantial impact on quality of life. This condition is initially triggered by the deposition of monosodium urate crystals into the joint space. This causes an inflammatory cascade resulting in the secretion of several proinflammatory cytokines and neutrophil recruitment into the joint. While generally effective, currently available agents are associated with a number of adverse events and contraindications that complicate their use. Based on our increased understanding of the inflammatory pathogenesis of gouty arthritis, several new agents are under development that may provide increased efficacy and reduced toxicity.",
keywords = "Chronic diseases, Gouty arthritis, Inflammation, Pathophysiology",
author = "Emilio Gonzalez",
year = "2012",
month = "1",
doi = "10.1007/s10067-011-1877-0",
language = "English (US)",
volume = "31",
pages = "13--21",
journal = "Clinical Rheumatology",
issn = "0770-3198",
publisher = "Springer London",
number = "1",

}

TY - JOUR

T1 - An update on the pathology and clinical management of gouty arthritis

AU - Gonzalez, Emilio

PY - 2012/1

Y1 - 2012/1

N2 - Gouty arthritis is an inflammatory condition associated with debilitating clinical symptoms, functional impairments, and a substantial impact on quality of life. This condition is initially triggered by the deposition of monosodium urate crystals into the joint space. This causes an inflammatory cascade resulting in the secretion of several proinflammatory cytokines and neutrophil recruitment into the joint. While generally effective, currently available agents are associated with a number of adverse events and contraindications that complicate their use. Based on our increased understanding of the inflammatory pathogenesis of gouty arthritis, several new agents are under development that may provide increased efficacy and reduced toxicity.

AB - Gouty arthritis is an inflammatory condition associated with debilitating clinical symptoms, functional impairments, and a substantial impact on quality of life. This condition is initially triggered by the deposition of monosodium urate crystals into the joint space. This causes an inflammatory cascade resulting in the secretion of several proinflammatory cytokines and neutrophil recruitment into the joint. While generally effective, currently available agents are associated with a number of adverse events and contraindications that complicate their use. Based on our increased understanding of the inflammatory pathogenesis of gouty arthritis, several new agents are under development that may provide increased efficacy and reduced toxicity.

KW - Chronic diseases

KW - Gouty arthritis

KW - Inflammation

KW - Pathophysiology

UR - http://www.scopus.com/inward/record.url?scp=84856727646&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856727646&partnerID=8YFLogxK

U2 - 10.1007/s10067-011-1877-0

DO - 10.1007/s10067-011-1877-0

M3 - Article

C2 - 22069122

AN - SCOPUS:84856727646

VL - 31

SP - 13

EP - 21

JO - Clinical Rheumatology

JF - Clinical Rheumatology

SN - 0770-3198

IS - 1

ER -